Adam Margolin, Eric Schadt
Mount Sinai's School of Medicine has hired Adam Margolin, former director of computational biology at Oregon Health & Science University, to lead a new initiative on data science and precision medicine. Margolin will take on the positions previously held by Eric Schadt, who was hired in 2011 to lead Mount Sinai's programs in data science and genomics. Schadt will continue at Mount Sinai in his role as dean for precision medicine at the school of medicine. He will also remain in his role as CEO of Mount Sinai diagnostics spinout Sema4, which provides noninvasive prenatal screening, genetic carrier screening, newborn genetic disease testing, and tumor genetic testing to personalize cancer treatments.
HTG Molecular Diagnostics has appointed Maureen Cronin as its CSO and senior vice president, effective Nov. 16. Cronin served as executive director of strategic information management for Celgene from 2012 to 2017. Before that, she was senior vice president of research and product development for Foundation Medicine. She also served as VP of translational research and senior director of technology development at Genomic Health.
Gene editing technology company Inscripta has appointed Jason Gammack as its first chief commercial officer. Gammack will design and oversee Inscripta's sales, marketing, business development, and customer support operations. He most recently served as vice president of Qiagen's life science business, where he led the development of the life science portfolio and go-to-market strategy. Prior to Qiagen, Gammack developed commercialization growth strategies at bioinformatics company Ingenuity Systems, which was acquired by Qiagen in 2013, and has also held senior leadership roles at Sigma-Aldrich, Life Technologies, Affymetrix, and Promega.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.